Pacer Advisors Inc. Makes New $3.81 Million Investment in Alnylam Pharmaceuticals, Inc. $ALNY
MarketBeat
Pacer Advisors Inc. acquired a new stake in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 9,588 shares of the biopharmaceutical company's stock, valued at approximately $3
NASDAQ:ALNY